date,title,source
Oct-29-18,ProQR In-licenses Worldwide Rights to Ophthalmology Drug Candidate from Ionis Pharmaceuticals,GlobeNewswire
Oct-31-18,ProQR Announces Presentations at the European Oligonucleotide and Peptide Therapeutics Conference,GlobeNewswire
